menu
    • menu

    Company profile for NanoAlvand

    Nanoalvand-PSE
    News
    Stomach Cancer Awareness Month

    01 Nov 2025

    // PRESS RELEASE

    Metastatic Breast Cancer Awareness Day Bringing Hope

    13 Oct 2025

    // PRESS RELEASE

    Tenoclax® - Venetoclax Oral Tablet (10, 50, and 100 mg)

    25 Sep 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    NanoAlvand VB RM

    Contact Supplier

    Website

    BIO Partnering at JPM

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/antibiotic-market-to-reach-us-74-07-billion-by-2033-fda-approves-gsk-s-blujepa-for-uncomplicated-utis

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    PharmaCompass

    NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Related CompaniesRelated Companies

    About

    NanoAlvand©, founded in 2011, is a premier pharmaceutical company dedicated to producing high-quality medications with a primary focus on oncology, rheumatology & neurology. We offer liquid, solid, and semi-solids-designed to meet diverse therapeutic needs & strong export ties across the Middle East, EAEU, and ASEAN, we are actively expanding into new international markets. Committed to quality, compliance & continuous innovation, we collaborate with top global suppliers and pursue strategic partnerships through joint ventures and technology transfer. We welcome suppliers, manufacturers, & distributors to join us-Our Hope Shapes The Future.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NanoAlvandIran Flag
    Country
    Country
    Iran
    Address
    Address
    Unit 52, 5th floor, No. 485, Between 63 St. & 65 St.,Asad Abadi St., Yousef A...
    Telephone
    Telephone
    +98 2191077339
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nanoalvand.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nano-alvand-pharmaceutical-co-/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-83967.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-90057.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Stomach Cancer Awareness Month
    Stomach Cancer Awareness Month

    01 Nov 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/215-stomach-cancer-awareness-month

    PRESS RELEASE
    01 Nov 2025
    Share Share
    Metastatic Breast Cancer Awareness Day Bringing Hope
    Metastatic Breast Cancer Awareness Day Bringing Hope

    13 Oct 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/218-metastatic-breast-cancer-awareness-day

    PRESS RELEASE
    13 Oct 2025
    Share Share
    Tenoclax® - Venetoclax Oral Tablet (10, 50, and 100 mg)
    Tenoclax® - Venetoclax Oral Tablet (10, 50, and 100 mg)

    25 Sep 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/212-tenoclax-release

    PRESS RELEASE
    25 Sep 2025
    Share Share
    Product Launch Amitzo® 100 mg Lyophilized Powder for Injection
    Product Launch Amitzo® 100 mg Lyophilized Powder for Injection

    10 Aug 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/207-temozolomide-release

    PRESS RELEASE
    10 Aug 2025
    Share Share
    HOPE in Action NanoAlvand’s Head & Neck Cancer Awareness
    HOPE in Action NanoAlvand’s Head & Neck Cancer Awareness

    27 Jul 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/209-head-neck

    PRESS RELEASE
    27 Jul 2025
    Share Share
    NanoAlvand Expands Trexoma® Portfolio with Methotrexate Tablets
    NanoAlvand Expands Trexoma® Portfolio with Methotrexate Tablets

    16 Jul 2025

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/206-methotrexate-release

    PRESS RELEASE
    16 Jul 2025
    Share Share

    Services

    Discover the service capabilities from this company

    Packaging

    Discover their expertise for : Packaging

    Analytical

    Discover their expertise for : Analytical

    Drug Product Manufacturing

    Discover their expertise for : Drug Product Manufacturing

    Sales, Marketing, Registration

    Discover their expertise for : Sales, Marketing, Registration

    API & Drug Product Development

    Discover their expertise for : API & Drug Product Development

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search